These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20632855)

  • 21. Advances and applications of induced pluripotent stem cells.
    Pietronave S; Prat M
    Can J Physiol Pharmacol; 2012 Mar; 90(3):317-25. PubMed ID: 22364544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
    Kumar D; Anand T; Kues WA
    Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ethical reflections on cell reprogramming].
    Aznar Lucea J; Martínez M
    Cuad Bioet; 2012; 23(78):287-99. PubMed ID: 23130744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical grade iPS cells: need for versatile small molecules and optimal cell sources.
    Wu YL; Pandian GN; Ding YP; Zhang W; Tanaka Y; Sugiyama H
    Chem Biol; 2013 Nov; 20(11):1311-22. PubMed ID: 24267275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viable iPSC mice: a step closer to therapeutic applications in humans?
    Betts DH; Kalionis B
    Mol Hum Reprod; 2010 Feb; 16(2):57-62. PubMed ID: 19952032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced pluripotent stem cells in research and therapy.
    Teoh HK; Cheong SK
    Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regenerative cells for transplantation in hepatic failure.
    Ishikawa T; Banas A; Teratani T; Iwaguro H; Ochiya T
    Cell Transplant; 2012; 21(2-3):387-99. PubMed ID: 22793046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for replacing myocytes with induced pluripotent stem in clinical protocols.
    Hattori F; Fukuda K
    Transplant Rev (Orlando); 2012 Jul; 26(3):223-32. PubMed ID: 22172453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cells and promises of neuroregenerative medicine.
    Verma A; Verma N
    Neurol India; 2011; 59(4):555-7. PubMed ID: 21891933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly efficient generation of definitive endoderm lineage from human induced pluripotent stem cells.
    Sekine K; Takebe T; Suzuki Y; Kamiya A; Nakauchi H; Taniguchi H
    Transplant Proc; 2012 May; 44(4):1127-9. PubMed ID: 22564643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for iPS cell generation for basic research and clinical applications.
    Mochiduki Y; Okita K
    Biotechnol J; 2012 Jun; 7(6):789-97. PubMed ID: 22378737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
    Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
    Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.